Analysis of COVID-19 booster shots for individuals over 65 and antibody levels post-infection.
-
Discussion on the potential need for a second bivalent booster for individuals over 65 due to a stockpile of updated shots. • 0:35
-
Research findings on antibody levels post-normal COVID-19 infection, with most individuals showing 179-800 nanograms per milliliter. • 2:02
-
Comparison of antibody levels post-infection versus post-vaccination to determine similar responses. • 3:46
Analysis of antibody levels in different age groups raises concerns about the need for Covid boosters.
-
Antibody levels above 800 nanograms per milliliter are prevalent in the population, especially in the 16-24 age group. • 4:11
-
Therapeutic ranges are crucial in determining the appropriate dosage of treatments to avoid potential risks. • 5:27
-
Over 65% of individuals aged 16-24 have antibody levels exceeding the 800 threshold, indicating potential overexposure to boosters. • 7:10
-
Some individuals in the population exhibit antibody levels over 6,000 nanograms per milliliter, significantly higher than the typical range. • 7:30
-
The average antibody level is around 300, but a considerable number of individuals, especially younger age groups, have levels well above this threshold. • 8:05
High antibody levels post-vaccination raise concerns about infection control effectiveness.
-
Majority of age groups have antibody levels above 800, with some over 6000. • 8:13
-
Current Omicron levels surpass those of January 2022, despite high antibody levels. • 10:02
-
Over 80s show antibody levels 20 times higher than normal infection rates. • 10:43
-
Presence of high antibody levels does not seem to correlate with infection control. • 11:02
-
Question raised on the effectiveness of high antibody levels in controlling infections. • 11:13